571 studies found for:    Open Studies | "Ovarian Diseases"
Show Display Options
Rank Status Study
1 Recruiting Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer
Conditions: Ovarian Diseases;   Ovarian Neoplasms
Interventions: Other: Laboratory Tumor Marker Analysis;   Other: Transvaginal Ultrasound;   Other: Health Status Questionnaire
2 Recruiting Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer
Intervention: Drug: BIBF 1120
3 Not yet recruiting Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Procedure: Cytoreductive Surgery (CRS);   Procedure: Hyperthermic Intraperitoneal Chemotherapy (HIPEC);   Drug: Systemic Chemotherapy
4 Recruiting A Study of Rucaparib as Switch Maintenance Following Platinum-Based Chemotherapy in Patients With Platinum-Sensitive, High-Grade Serous or Endometrioid Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer;   Peritoneal Cancer
Interventions: Drug: Rucaparib;   Drug: Placebo
5 Recruiting A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Patients With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer
Condition: Ovarian Cancer, Pancreatic Cancer
Interventions: Drug: DMCU4064A;   Drug: DMUC4064A
6 Unknown  Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction;   Cervical Cancer;   Endometrial Cancer;   Esophageal Cancer;   Fallopian Tube Cancer;   Gastric Cancer;   Ovarian Cancer;   Sarcoma;   Vaginal Cancer;   Vulvar Cancer
Interventions: Other: informational intervention;   Procedure: assessment of therapy complications;   Procedure: psychosocial assessment and care
7 Recruiting Chk1/2 Inhibitor (LY2606368) in Women With BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Non-High Risk Triple Negative Breast Cancer, and High Grade Serous Ovarian Cancer at Low Genetic Risk
Conditions: Ovarian Cancer;   Breast Cancer
Intervention: Drug: LY2606368
8 Unknown  Simvastatin and Metformin Therapy in PCOS Women. Prospective Randomised Trial.
Condition: Polycystic Ovary Syndrome
Interventions: Drug: Simvastatin;   Drug: Simvastatin and Metformin;   Drug: Metformin
9 Recruiting Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Carcinoma;   Peritoneal Carcinoma
Intervention: Drug: carboplatin and paclitaxel followed by surgery
10 Recruiting Bevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian Cancer
Condition: Ovarian Epithelial Cancer Recurrent
Interventions: Drug: bevacizumab and trabectedin;   Drug: bevacizumab, trabectedin and carboplatin
11 Recruiting A Phase 1 Trial of Perfusion Induced Systemic Hyperthermia (PISH) Over Multiple Cycles for Terminal Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Device: ThermalCore Hyperthermia System
12 Recruiting EGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: Ovarian Clear Cell Cystadenocarcinoma;   Ovarian Endometrioid Adenocarcinoma;   Ovarian Mixed Epithelial Carcinoma;   Ovarian Serous Cystadenocarcinoma;   Ovarian Undifferentiated Adenocarcinoma;   Recurrent Fallopian Tube Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Primary Peritoneal Cavity Cancer
Interventions: Biological: EGEN-001;   Drug: pegylated liposomal doxorubicin hydrochloride;   Other: laboratory biomarker analysis
13 Recruiting Heated Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Peritoneal Cancer
Conditions: FIGO Stage IIC-IV Ovarian Carcinoma;   Fallopian Tube Carcinoma;   Peritoneal Carcinoma
Intervention: Drug: carboplatin
14 Recruiting Pazopanib Hydrochloride, Paclitaxel, and Carboplatin in Treating Patients With Refractory or Resistant Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Primary Peritoneal Cavity Cancer
Interventions: Drug: carboplatin;   Drug: paclitaxel;   Drug: pazopanib hydrochloride;   Other: laboratory biomarker analysis;   Other: pharmacological study
15 Recruiting Adipose Tissue and Polycystic Ovary Syndrome (PCOS)(EIFFEL)
Conditions: Polycystic Ovary Syndrome;   Metabolic Diseases;   Overweight
Intervention:
16 Unknown  Whole Genome Analysis for the Detection of Key Genes in the Polycystic Ovary Syndrome
Conditions: Anovulation;   Hyperandrogenism;   Polycystic Ovary Syndrome;   Single Nucleotide Polymorphism
Intervention:
17 Recruiting Phase II Study of NGR-hTNF in Combination With Doxorubicin in Platinum-resistant Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: NGR-hTNF;   Drug: Pegylated liposomal doxorubicin;   Drug: Doxorubicin
18 Recruiting Nutritional and Metabolic Correlates of Ovarian Morphology in Women With Polycystic Ovary Syndrome
Conditions: Polycystic Ovary Syndrome (PCOS);   Menstrual Irregularity
Intervention:
19 Recruiting The Genetic Investigation of Reproductive Disorders (Including Kallmann Syndrome)
Conditions: Kallmann Syndrome;   Hypogonadotropic Hypogonadism;   Hypothalamic Amenorrhea;   Polycystic Ovarian Syndrome;   Precocious Puberty
Intervention:
20 Recruiting Sentinel Node in Ovarian Cancer
Conditions: Ovarian Cancer;   Sentinel Node
Intervention: Procedure: blue dye and radioactive tracer

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years